HCM
MRNA icon

Highline Capital Management’s Moderna MRNA Stock Holding History

Highline Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-250,000
Closed -$7.49M – 28
2020
Q1 		$7.49M Buy
250,000
+100,000
+67% +$2.3M 1.82% 18
2019
Q4 		$2.93M Buy
+150,000
New +$2.66M 0.46% 20
2019
Q2 		– Sell
-930,230
Closed -$18.9M – 37
2019
Q1 		$18.9M Sell
930,230
-587,712
-39% -$10.9M 1.19% 25
2018
Q4 		$23.2M Buy
+1,517,942
New +$24.9M 1.55% 21

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Highline Capital Management's MRNA Position: Q2 2020 in Review

Highline Capital Management sold out of Moderna (MRNA) in Q2 2020, closing a stake of 250,000 shares — an estimated $7.49M sold.

Highline Capital Management first reported a position in MRNA in Q4 2018 and held it in 4 quarters. The position peaked at $23.2M in Q4 2018. 489 funds tracked by Wall St. Rank hold MRNA as of Q2 2020.

  • Highline Capital Management reported no remaining Moderna position as of Q2 2020 after selling out during the quarter.
  • Highline Capital Management sold 250,000 Moderna shares in Q2 2020, an estimated $7.49M.
  • Highline Capital Management first reported a position in Moderna in Q4 2018 and held it in 4 quarters.
  • Highline Capital Management's Moderna position peaked at $23.2M in Q4 2018.
  • 489 funds tracked by Wall St. Rank held Moderna as of Q2 2020.

Based on Highline Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.